Focus Areas

Innovative Neuro Research


Recurrent, unprovoked seizures

  • Spontaneous seizure development
  • Post Traumatic Epilepsy
  • Specializing in reproducing seizures in the lab


Affecting neurons in the brain

  • Animal Model Development
  • Alzheimer's
  • Parkinson's


Innovative Techniques

  • Neurodegenerative diseases
  • Epilepsy
  • Traumatic brain injury

Other Research

Growing interest in

  • Biomarker development
  • Non-invasive Nuerostimulation
  • Human Microbiome ``The Second Brain``

Patents Pending

Current Projects at Expesicor
People with Epilepsy
Traumatic Brain Injury (TBI) cases each year
People with Alzheimer's and Parkinson's
Meet the Team

Expesicor Leadership

Braxton Norwood PhD
CEO & Director of Neuroscience
Neuroscientist with substantial experience in epilepsy R&D. NIH Young Investigator Award. CURE Foundation Challenge Award.
David Booth
COO & Chairman of the Board
Serial entrepreneur and investor
Expect a response within 48 hours
Contact Us

“Epilepsy R&D is long overdue for a breakthrough, and the KaL method may be just that.”

Tom Swanson MD, Director of the MT Comprehensive Epilepsy Center

July Update – Expesicor receives a $101,250 grant from the Montana Department of Commerce.

Access the recommendation on F1000